Testing effectiveness (Phase 2)Ended earlyNCT00485563
What this trial is testing
A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma
Who this might be right for
Renal Cell Carcinoma
Endocyte 12